<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Lateral sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> (LST) is an uncommon, but life-threatening complication of both <z:hpo ids='HP_0011009'>acute</z:hpo> and <z:hpo ids='HP_0000389'>chronic otitis media</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>There is some evidence that acquired or hereditary prothrombotic disorders are risk factors for LST </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this work was to evaluate the role of thrombotic screening, <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy or prophylaxis in patients with either <z:hpo ids='HP_0011009'>acute</z:hpo> or <z:hpo ids='HP_0000389'>chronic otitis media</z:hpo> and LST </plain></SENT>
<SENT sid="3" pm="."><plain>The medical records of five children hospitalized at Pediatric Hospital Bambino Ges√π of Rome because of <z:hpo ids='HP_0011009'>acute</z:hpo> or <z:hpo ids='HP_0000389'>chronic otitis media</z:hpo> complicated by <z:hpo ids='HP_0000265'>mastoiditis</z:hpo> and LST were reviewed </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> children underwent laboratory workup for <z:hpo ids='HP_0100724'>hypercoagulability</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the five children were found to be heterozygote for the C677T MTHFR mutation and a child presented also heterozygosity for <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>They have been successfully treated with <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy without sequels </plain></SENT>
<SENT sid="7" pm="."><plain>Children with <z:hpo ids='HP_0011009'>acute</z:hpo> or <z:hpo ids='HP_0000389'>chronic otitis media</z:hpo> may have a prothrombotic tendency that becomes clinically evident because of the inflammatory state </plain></SENT>
<SENT sid="8" pm="."><plain>Patients with a family and/or personal history of <z:mp ids='MP_0005048'>thrombosis</z:mp> and/or thrombophilic conditions need <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> prophylaxis also in the absence of clear signs of LST </plain></SENT>
<SENT sid="9" pm="."><plain>Treatment with low molecular weight is successful in patients with LST </plain></SENT>
</text></document>